کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2407903 1103147 2008 16 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Host genetic factors that control immune responses to retrovirus infections
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
پیش نمایش صفحه اول مقاله
Host genetic factors that control immune responses to retrovirus infections
چکیده انگلیسی

SummarySeveral host genes control retroviral replication and pathogenesis. These include genes that directly affect the replication of retroviruses in target cells and those that control the host immune responses to the viral antigens. Host genetic factors that affect retroviral replication and immune responses to the viral antigens have been best studied in mouse models of Friend leukemia virus (FV) infection. Several genes located within the major histocompatibility complex (MHC), along with a separate gene not linked to the MHC, influence the host immune responses to FV antigens. The latter, the Rfv3, regulates the production of virus-neutralizing antibodies, and thus affects the duration of viremia. T-cell responses to the viral epitopes are controlled by MHC class I and class II genotypes, and both CD8+ and CD4+ T-cells are required for spontaneous immune resistance to FV infection. When CD4+ T-helper cells are efficiently primed with a viral epitope, however, CD8+ T-cells are not required for immune protection against FV infection, while B cells are absolutely required. There are individuals who possess human immunodeficiency virus type 1 (HIV-1)-reactive IgA antibodies in their mucosal secretions and show strong T-cell responses to HIV-1 antigens, even though they are negative for HIV-1 genome and HIV-1-reactive serum IgG. These HIV-1-exposed but uninfected individuals rarely possess resistance-associated alleles at known AIDS-restricting loci such as CCR5Δ32. Recent genetic analyses have indicated that a large proportion of such exposed but uninfected individuals may share a common genetic background.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 26, Issue 24, 6 June 2008, Pages 2981–2996
نویسندگان
, , ,